Altimmune (ALT) Non-Current Debt (2012 - 2026)

Altimmune (ALT) has 13 years of Non-Current Debt data on file, last reported at $34.5 million in Q1 2026.

• On a quarterly basis, Non-Current Debt changed N/A year-over-year to $34.5 million in Q1 2026; TTM through Mar 2026 was $34.5 million, a N/A change from a year earlier, with the FY2025 full-year figure at $34.3 million, changed N/A from the prior year.
• Non-Current Debt for Q1 2026 stood at $34.5 million, up from $34.3 million in the prior quarter.
• Over the last five years, Non-Current Debt for ALT reached as high as $34.5 million in Q1 2026 and fell as low as $1.5 million in Q2 2022.
• Historically, Non-Current Debt has averaged $11.2 million across 4 years, with a median of $4.5 million in 2022.
• On a YoY basis, Non-Current Debt climbed as much as 215.06% in 2022 and fell as far as 5.64% in 2022.
• Year by year, Non-Current Debt stood at $4.6 million in 2022, then retreated by 6.02% to $4.3 million in 2023, then surged by 696.45% to $34.3 million in 2025, then climbed by 0.64% to $34.5 million in 2026.
• Per Business Quant data, the three most recent Non-Current Debt figures were $34.5 million in Q1 2026, $34.3 million in Q4 2025, and $14.4 million in Q3 2025.